Pattini et al. [27] indicated that MAGEB2 is activated by promoter demethylation in head and neck squamous cell carcinoma (HNSCC), which has growth promoting effects on a minimally transformed oral keratinocyte cell line. Here, MAGEB2 is linked to head and neck squamous cell carcinoma.